PET Labelled Probes for Cancer Patient Stratification

Roderick StarkStudent: Roderick Stark
Supervisor: Dr Ian Fallis
Location: Cardiff University
Cancer Type: All – Cancer treatment
Start and End Date: Oct 2016 – Sep 2019

The future clinical relevance of this work is that since the proposed tracers will be pharmacologically identical to gemcitabine and its pro-drug analogues, their PET assayed uptake will be a direct indicator of their suitability of these agents in the treatment to an individual patient. This would represent an important step towards personalised cancer care facilitated by a single non-invasive scan.

<< Go Back